Severe Illness, Death Reported With Misuse of Non-Pharmaceutical Chloroquine for COVID-19 “Prevention”
The product that sickened the couple was in powder form and was labeled “for Ornamental Fish Use Only.”
General Cardiology
FDA Allows Use of COVID-19 Convalescent Plasma for Severely Ill Patients Under Emergency IND
Convalescent plasma, which is collected from patients who have recovered from COVID-19, contains antibodies to SARS-CoV-2, the virus that causes the disease.
Abbott’s Point-of-Care COVID-19 Test Delivers Results Within Minutes
The FDA has issued an Emergency Use Authorization for the Abbott ID Now™ COVID-19 test.
The Many Benefits of Exercise in Adults, Children With Fontan Circulation
Exercise may bring a wide range of benefits to adult and pediatric patients with Fontan circulation.
Americans’ Protein-Rich Diets May Increase Heart Disease Risk
Findings may have important public health implications for chronic disease prevention.
Psoriasis in Adolescents Linked to Cardiometabolic Risk Factors
Early markers of cardiovascular and metabolic disease were elevated in adolescents with psoriasis, despite early disease.
Opportunities Identified for Improving BP Control
Based on EHR data, room for improvement found in BP control, health care processes such as meds intensification
Olive Oil Consumption Tied to Lower Cardiovascular Risk
Substituting margarine, butter, mayonnaise, and dairy fat with olive oil may lower risk.
RAS Blockade Discontinuation Tied With Death, MACE in Advanced Kidney Disease
Study findings suggest the benefits of continuing ACEi or ARB therapy outweigh the risks in CKD patients with an eGFR less than 30 mL/min/1.73 m2.
Joint Statement Issued Addressing Concerns Over COVID-19 and ACE Inhibitor, ARB Use
Patients with cardiovascular disease diagnosed with novel coronavirus (COVID-19) are urged to continue taking their angiotensin-converting enzyme inhibitor (ACEi) and angiotensin receptor blocker (ARB) medications as prescribed.
Next post in General Cardiology
